[XENE] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -4.91%
YoY- -0.36%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 16 264 15 16 376 -
PBT -7,801 -3,755 -8,065 -7,742 -7,380 -7,517 -6,004 19.12%
Tax 200 159 14 -902 -513 -470 542 -48.64%
NP -7,801 -3,755 -8,065 -7,742 -7,380 -7,517 -6,004 19.12%
Tax Rate - - - - - - - -
Total Cost 7,801 3,755 8,081 8,006 7,395 7,533 6,380 14.38%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 -50,406.25 -2,932.58 -49,200.00 -46,981.25 -1,596.81 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.55 -0.22 -0.45 -0.43 -0.41 -0.42 -0.33 40.70%
EPS Diluted -0.55 -0.21 -0.45 -0.43 -0.41 -0.42 -0.33 40.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.